References
-
1
Akiskal HS, Hantouche EG, Allilaire JF. et al .
Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II).
J Affect Disord.
2003;
73
65-74
-
2
Atmaca M, Kuloglu M, Buyukbayram A. et al .
Quetiapine-associated and dose-related hypomania in a woman with schizophrenia.
Eur Psychiatry.
2002;
17
292-293
-
3
Aubry JM, Simon AE, Bertschy G.
Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases.
J Clin Psychiatry.
2000;
61
649-655
-
4
Berman RM, Marcus RN, Swanink R. et al .
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.
J Clin Psychiatry.
2007;
68
843-853
-
5
Burris KD, Molski TF, Xu C. et al .
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.
J Pharmacol Exp Ther.
2002;
302
381-389
-
6
Davis R, Risch SC.
Ziprasidone induction of hypomania in depression?.
Am J Psychiatry.
2002;
159
673-674
-
7
Diaz SF.
Mania associated with risperidone use.
J Clin Psychiatry.
1996;
57
41-42
-
8
Donohue A.
First manic episode in a 55-year-old man after initiation of aripiprazole.
Psychiatry (Edgmont).
2010;
7
37-39
-
9
Faedda GL, Tondo L, Baldessarini RJ. et al .
Outcome after rapid vs. gradual discontinuation of lithium treatment in bipolar disorders.
Arch Gen Psychiatry.
1993;
50
448-455
-
10
Fitz-Gerald MJ, Pinkofsky HB, Brannon G. et al .
Olanzapine-induced mania.
Am J Psychiatry.
1999;
156
1114
-
11
Henry C, Demotes-Mainard J.
Olanzapine-induced mania in bipolar disorders.
J Psychiatry Neurosci.
2002;
27
200-201
-
12
Jordan S, Koprivica V, Chen R. et al .
The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor.
Eur J Pharmacol.
2002;
441
137-140
-
13
Kane JM, Fleischhacker WW, Hansen L. et al .
Akathisia: an updated review focusing on second-generation antipsychotics.
J Clin Psychiatry.
2009;
70
627-643
-
14
Keating AM, Aoun SL, Dean CE.
Ziprasidone-associated mania: a review and report of 2 additional cases.
Clin Neuropharmacol.
2005;
28
83-86
-
15
Lykouras L, Oulis P, Hatzimanolis J.
Manic symptoms associated with quetiapine treatment.
Eur Neuropsychopharmacol.
2003;
13
135-136
-
16
Marcus RN, McQuade RD, Carson WH. et al .
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
J Clin Psychopharmacol.
2008;
28
156-165
-
17
McDaniel JS, Ninan PT, Magnuson JV.
Possible induction of mania by buspirone.
Am J Psychiatry.
1990;
147
125-126
-
18
Padala PR, Wengel SP, Petty F.
Manic episode during treatment with aripiprazole.
Am J Psychiatry.
2007;
164
172-173
-
19
Rachid F, Bertschy G, Bondolfi G. et al .
Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases.
J Clin Psychiatry.
2004;
65
1537-1545
-
20
Stahl SM.
Do dopamine partial agonists have partial efficacy as antipsychotics?.
CNS Spectr.
2008;
13
279-282
-
21
Stark AD, Jordan S, Allers KA. et al .
Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors: functional receptor-binding and in vivo electrophysiological studies.
Psychopharmacology (Berl).
2007;
190
373-382
-
22
Thase ME, Jonas A, Khan A. et al .
Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
J Clin Psychopharmacol.
2008;
28
13-20
-
23
Tomlinson WC.
Rispiridone and mania.
Am J Psychiatry.
1996;
153
132-133
-
24
Traber R, Schneiter R, Modestin J.
A case of aripiprazole-induced mania.
Pharmacopsychiatry.
2007;
40
37-38
-
25
Zahodne LB, Fernandez HH.
Pathophysiology and treatment of psychosis in Parkinson's disease: a review.
Drugs Aging.
2008;
25
665-682
Correspondence
M. ViikkiMD, PhD
University of Tampere
Medical School
33014 University of Tampere
Finland
Telefon: +358/50/339 6646
Fax: +358/3/3551 6164
eMail: merja.viikki@gmail.com
